David Bunton

David Bunton is an accomplished business leader with extensive experience in the life sciences sector. Currently serving as the CEO of REPROCELL Europe Ltd since July 2016, David oversees European operations following the merger of Biopta Ltd and Reinnervate Ltd. Additionally, David holds the position of Chairperson at the Precision Medicine Scotland Innovation Centre since May 2020. David founded and previously served as CEO of Biopta Inc. from January 2012 to September 2016 and was the CEO of Biopta Ltd from September 2002 to June 2016, providing non-clinical human tissue-based pharmacology services. Prior to these roles, David was a lecturer at Glasgow Caledonian University from April 1998 to September 2004. David's academic credentials include a PhD in Physiology from Glasgow Caledonian University and a degree in Physiology from the University of Glasgow, complemented by a management program at MIT Sloan School of Management in 2010.